z-logo
Premium
Assessment of the role of brassinosteroid in regulating the disease resistance of postharvest tomato fruit by proteomic analysis
Author(s) -
Ding Yang,
Sheng Jiping,
Cheng Fansheng
Publication year - 2021
Publication title -
journal of food processing and preservation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.511
H-Index - 48
eISSN - 1745-4549
pISSN - 0145-8892
DOI - 10.1111/jfpp.15708
Subject(s) - phenylpropanoid , brassinosteroid , postharvest , phenylalanine ammonia lyase , plant disease resistance , biology , alternaria solani , solanum , enzyme , biochemistry , gene , botany , biosynthesis , fungicide , arabidopsis , peroxidase , mutant
Abstract This study aimed to investigate the effects of brassinosteroid (BR) on disease development, disease resistance‐related enzyme activities, gene expression, and proteomic change in tomato ( Solanum lycopersicum ) fruits infected by Alternaria solani . The results showed that BR pretreatment inhibited disease development and increased the activities of disease resistance‐related enzymes. Fruits treated by brassinazole, the biosynthesis inhibitor of BR, are more sensitive to A .  solani . BR could promote the gene expression of downstream and upstream in the systematic acquired resistance (SAR) pathways and the catalyzers in the biosynthetic pathways of phenolic and quinone compounds. The proteomic analysis showed that BR upregulated the expression of 2 proteins and downregulated the expression of 13 proteins. Furthermore, one upregulated protein was involved in the phenylpropanoid biosynthetic pathway. These results suggested that BR‐mediated disease resistance in tomato fruits could share some SAR downstream genes and phenylalanine ammonia‐lyase and also have distinct pathways. Practical applications Brassinosteroid treatment before harvest could be a useful strategy to improve the quality of tomato fruit and reduce postharvest losses caused by fungi disease.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here